Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Pilot Trial

OBJECTIVE: To explore the safety and tolerability of atacicept in combination with rituximab in patients with active rheumatoid arthritis (RA) receiving rituximab re‐treatment. METHODS: In this randomized, double‐blind, placebo‐controlled pilot trial, 2 infusions (1,000 mg per infusion) of intraveno...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, R. F., Wax, S., Li, Y., Tak, P. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057363/
https://www.ncbi.nlm.nih.gov/pubmed/26137975
http://dx.doi.org/10.1002/art.39262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057363/
https://www.ncbi.nlm.nih.gov/pubmed/26137975
http://dx.doi.org/10.1002/art.39262

Ejemplares similares